KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Shares Issued (2016 - 2025)

Exact Sciences (EXAS) has disclosed Shares Issued for 16 consecutive years, with $10.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 11.11% to $10.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.3 million, a 6.25% decrease, with the full-year FY2025 number at $26.5 million, down 15.0% from a year prior.
  • Shares Issued was $10.5 million for Q4 2025 at Exact Sciences, down from $11.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $15.4 million in Q2 2023 to a low of $558000.0 in Q4 2022.
  • A 5-year average of $6.7 million and a median of $6.5 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 94.94% in 2022, then surged 2050.54% in 2023.
  • Exact Sciences' Shares Issued stood at $11.0 million in 2021, then crashed by 94.94% to $558000.0 in 2022, then soared by 2050.54% to $12.0 million in 2023, then dropped by 1.46% to $11.8 million in 2024, then decreased by 11.11% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Shares Issued are $10.5 million (Q4 2025), $11.8 million (Q4 2024), and $12.0 million (Q4 2023).